Advocacy Group: Pharmaceutical Companies Top List of DOJ Settlements

The False Claims Act has proven to be effective and efficient in recovering taxpayer money stolen by perpetrators of fraud, according to a report by advocacy group Taxpayers Against Fraud.

In fiscal year 2010, the Department of Justice recovered more than $3.1 billion from whistleblower lawsuits and False Claims Act prosecutions. TAF calculated that the FCA recovered more than $15 for every dollar invested in healthcare investigations and prosecutions.

Additionally, TAF reported that of the top 10 FCA settlements that occurred in FY 2010, eight of the settlements involved fraud committed by pharmaceutical companies. The top 10 settlements recovered approximately $2.7 billion. The top FCA settlement was $600 million paid by Allergan, a pharmaceutical company that promoted off-label use of its product Botox, according to the news report.

Read the TAF report about False Claims Act in 2010.

Read other coverage about the False Claims Act:

- Justice Department Can Join Whistleblower False Claims Suit Against St. Jude Medical

- Justice Department Joins False Claims Lawsuit Against Georgia's Satilla Regional Medical Center and Physician

- New Hampshire Hospital Settles Federal Investigation

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

/30116360/ASC_Homepage_300x250-1

/30116360/ASC_Homepage_300x250-2

Featured Webinars

Featured Whitepapers